<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIM: The familial aggregation of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the gastroesophageal junction, jointly termed familial <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, may represent a complex genetic trait </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine the proportion of patients with these diseases who have familial <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Information on <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms, known risk factors for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and family history of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, was collected at six hospitals using a structured questionnaire from probands with either long-segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the gastroesophageal junction </plain></SENT>
<SENT sid="3" pm="."><plain>Family history of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> in a first- or second-degree relative was determined by reviewing medical records of <z:hpo ids='HP_0000001'>all</z:hpo> relatives reported to be affected </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Seventy one of 411 (17.3%) probands reported an affected first- and/or second-degree relative </plain></SENT>
<SENT sid="5" pm="."><plain>Upon review of medical records of the reportedly affected relatives, familial <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was definitively determined in the case of 30 (7.3%) probands comprising 17 of 276 (6.2%) with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, 11 of 116 (9.5%) with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, and 2 of 21 (9.5%) with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the gastroesophageal junction </plain></SENT>
<SENT sid="6" pm="."><plain>The diagnosis in the relative reported by the proband to be affected was found not to be <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in 15 (3.6%) cases </plain></SENT>
<SENT sid="7" pm="."><plain>The diagnosis could not be determined in 26 (6.3%) cases in which the proband reported an affected relative </plain></SENT>
<SENT sid="8" pm="."><plain>There were no significant differences in age of disease <z:hpo ids='HP_0003674'>onset</z:hpo>, gender, race, or <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> symptoms between definitive familial <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> probands and nonfamilial probands </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Familial <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> can be confirmed in 7.3% of persons presenting with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the gastroesophageal junction </plain></SENT>
</text></document>